Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00698789

Public ClinicalTrials.gov record NCT00698789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 7:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo Controlled, Randomized Study to Evaluate the Safety and Tolerability of INCB019602 Plus Metformin Compared to Metformin Alone in Type 2 Diabetic Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Determine the effect of treatment with INCB019602 administered as an add-on to stable dose metformin therapy in type 2 diabetic subjects on safety and glycemic control.

Study identification

NCT ID
NCT00698789
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Incyte Corporation
Industry
Enrollment
48 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2008
Primary completion
Jan 31, 2009
Completion
May 31, 2009
Last update posted
Oct 29, 2012

2008 – 2009

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
Not listed Phoenix Arizona 85029
Not listed Tucson Arizona 85705
Not listed Chula Vista California 91911
Not listed Los Angeles California
Not listed Mission Viejo California 92691
Not listed Orange California 92869
Not listed Paramount California 90723
Not listed San Diego California 92117
Not listed Santa Ana California 92701
Not listed Tustin California 92780
Not listed Colorado Springs Colorado 80909
Not listed St. Petersburg Florida 33709
Not listed Shawnee Mission Kansas 66216
Not listed Shreveport Louisiana 71101
Not listed Dearborn Michigan 48126
Not listed St Louis Missouri 63110
Not listed Omaha Nebraska 68154
Not listed Elizabeth New Jersey 07202
Not listed Charlotte North Carolina 28211
Not listed Oklahoma City Oklahoma 73103
Not listed East Providence Rhode Island 02914
Not listed San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00698789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2012 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00698789 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →